Disclosures for "Early Alzheimer’s Disease Diagnosis and Blood Biomarkers: Primary Care Physician Attitudes, Perceptions, and Barriers in the USA"
-
Dr. Alford has received personal compensation for serving as an employee of Novo Nordisk, Inc.. Dr. Alford has stock in Novo Nordisk.
-
Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
-
Ms. Coppinger has received personal compensation for serving as an employee of C2N Diagnostics, LLC. Ms. Coppinger has stock in C2N Diagnostics, LLC.
-
Marti Jimenez Mausbach has received personal compensation for serving as an employee of Novo Nordisk. Marti Jimenez Mausbach has stock in Novo Nordisk.
-
Dr. LAIRD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TZMO USA-Seni. The institution of Dr. LAIRD has received research support from Eli Lilly Community Grant.
-
Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIOHAVEN.
-
Dr. Ray has received personal compensation for serving as an employee of C2N Diagnostics.
-
Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.